MAPT and Alzheimer disease: In AD models, naringenin improves spatial learning and memory, modulates the PI3K/AKT/GSK-3β pathway, reduces tau phosphorylation, restores insulin signaling and PPAR-γ activity, and confers both metabolic and neuroprotective benefits (123, 124).